Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
    • Transskriptioner
    • AGM Invitations
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Pressemeddelelse

Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 May 2025 – 31 January 2026

Qlucore

Qlucore’s interim report for the period 1 May 2025 – 31 January 2026 will be published 26 February 2026.

Qlucore invites you to a video conference where the interim report will be presented by the CEO. There will be a Q&A session after the presentation. The presentation will be in Swedish. Questions can be asked in English.

Date: Thursday 26th of February at 10.30 am CET.

Meeting link (Teams): Connect

Certified Advisor


FNCA Sweden AB
Web: www.fnca.se

Contacts


Carl-Johan Ivarsson, CEO
Phone: +46 (0) 46 286 31 10
Email: carl-johan.ivarsson@qlucore.com 

About Qlucore


Qlucore develops AI‑based software that enables more accurate diagnostics and a more cost‑efficient healthcare system. Through the company’s precision medicine solutions, tens of thousands of genetic data points are transformed into clear decision‑making support, making it possible to deliver the right treatment to each patient at the right time.

The first diagnostic test – for pediatric blood cancer – has been approved for sale within the EU. Additional tests, including for lung cancer, adult blood cancer, and bladder cancer, are under development. These products target large and growing markets with significant medical and economic needs. The goal is to improve treatment outcomes, reduce human suffering, and lower healthcare costs.

In addition to its diagnostics portfolio, Qlucore offers Qlucore Omics Explorer, an established software platform for advanced data analysis used by researchers and pharmaceutical companies worldwide. The company has customers in about 20 countries, sales offices in Europe and North America, and distributors across several Asian markets.

Qlucore is listed on Nasdaq First North Growth market. More information: www.qlucore.com

Attachments


Invitation to presentation including Q&A session of Qlucore’s interim report for the period 1 May 2025 – 31 January 2026

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.